Natural antimicrobial susceptibility patterns of Kluyvera ascorbata and Kluyvera cryocrescens strains and review of the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections

Journal of Chemotherapy

Volumn 17, Issue 2, 2005, Pages 143-160

  Stock, I ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE   (Germany)

Author keywords

Antimicrobial therapy; Class A beta lactamase; Kluyvera ascorbata; Kluyvera cryocrescens; MIC; Natural antibiotic susceptibility; Naturally resistant; Naturally sensitive

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AXETIL; AZITHROMYCIN; AZLOCILLIN; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFDINIR; CEFEPIME; CEFETAMET; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFOTIAM; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTIBUTENE; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CETHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DICLOXACILLIN; DOXYCYCLINE; ENOXACIN; ERYTHROMYCIN; FLEROXACIN; FOLIC ACID ANTAGONIST; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; KANAMYCIN; LATAMOXEF; LINCOMYCIN; LINCOSAMIDE; LINEZOLID; LORACARBEF; MACROLIDE; MEROPENEM; MEZLOCILLIN; MINOCYCLINE; NAFCILLIN; NEOMYCIN; NETILMICIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; PEFLOXACIN; PENICILLIN G; PIPEMIDIC ACID; PIPERACILLIN; QUINOLONE DERIVATIVE; QUINUPRISTIN; RIFAMPICIN; ROXITHROMYCIN; SPARFLOXACIN; SPECTINOMYCIN; STREPTOGRAMIN; STREPTOMYCIN; SULBACTAM; SULFAMETHOXAZOLE; SULTAMICILLIN; TEICOPLANIN; TELITHROMYCIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TICARCILLIN; TIMENTIN; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; UREIDOPENICILLIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; ENTEROBACTER INFECTION; HUMAN; KLUYVERA CRYOCRESCENS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; SPECIES DIFFERENCE; VALIDATION PROCESS;

EID: 19644383395     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.2.143     Document Type: Article

References (47)

1. Farmer JJ III, Fanning GR, Huntley-Carter GP, Holmes B, Hickman FW, Richard C, Brenner DJ. Kluyvera, a new (redefined) genus in the family Enterobocteriaceae: Identification of Kluyvera ascorbota sp. nov. and Kluyvera cryocrescens sp. nov. in clinical specimens. J Clin Microbiol 1981; 13: 919-33.
2. Böttger EC, Jürs M, Barrett T, Wachsmuth K, Metzger S, Bitter-Suermann D. Qualitative and quantitative determination of enterobacterlal common antigen (ECA) with monoclonal antibodies: expression of ECA by two Actinobacillus species. J Clin Microbiol 1987; 25: 377-82.
3. Asai T, lizuka H, Komagata K. The flagellation of genus Kluyvera. J Gen Appl Microbiol 1962; 8: 187-91.
4. Asai T, Okumura S, Tsunoda T. On a new genus, Kluyvera. Proc Jpn Acad 1956; 32: 488-93.
5. Müller HE, Brenner DJ, Fanning GR, Grimont PAD, Kämpfer P. Emended description of Buttiauxella ogrestis with recognition of six new species of Buttiauxella and two new species of Kluyvera: Buttiauxella ferragutiae sp. nov., Buttiauxella gaviniae sp. nov., Buttiauxella brennerae sp. nov., Buttiauxella izardii sp. nov., Buttiauxella noackiae sp. nov., Buttiauxella warmboliae sp. nov., Kluyvera cochleae sp. nov., and Kluyvera georgiana sp. nov. Int J Syst Bacteriol 1996; 46: 50-63.
6. Farmer JJ III, Davis BR, Hickman-Brenner FW, McWhorter A, Huntley-Carter GP, Asbury MA, Riddle C, Wathen-Grady HG, Elias C, Fanning GR, Steigerwalt AG, O'Hara C, Morris GK, Smith PB, Brenner DJ. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol 1985; 21: 46-76.
7. Sarria JC, Vidai AM, Kimbrough RC III. Infections caused by Kluyvera species in humans. Gin Infect Dis 2001; 33: e69-74.
8. Braunstein H. A biotype of Enterobacteriaceae between Citrobacter and Enterobacter. Am J Clin Pathol 1980; 73; 114-16.
9. Fainstein V, Hopfer RL, Mills K, Bodey GP. Colonization by or diarrhoea due to Kluyvera species. J Infect Dis 1982; 145: 127.
10. Wong VK. Broviac catheter infection with Kluyvera cryocrescens: a case report. J Clin Microbiol 1987; 25: 1115-6.
11. Tristam DA, Forbes BA. Kluyvera: a case report of urinary tract infection and sepsis. Pediatr Infect Dis J 1988; 7: 297-8.
12. Sierra-Madero J, Part K, Hall GS, Stewart RW, Scerbo JJ, Longworth DL. Kluyvera mediastinitis following open-heart surgery: a case report. J Clin Microbiol 1990; 28: 2848-9.
13. Padilla E, Tudela P, Gimenez M, Gimeno JM. Bacteriemia por Kluyvera ascorbata. Med Clin (Bare) 1997; 108: 479.
14. Oteo J, Goméz-Garcés JL, Alós JI. Acute cholecystitis and bacteremia caused by Kluyvera ascorbata in a cirrhotic patient. Clin Microbiol Infect 1998; 4: 113-5.
15. Linares P, Castañón C, Llano C, Diz P, García-Palomo A, González LM, Fernández-Natal I. Bacteriemia por Kluyvera ascorbata en un paciente con neutropenia y fiebre. Enferm Infecc Microbiol Clin 2000; 18: 48-9.
16. Lin JC, Chen CH, Siu LK, Chang FY. Nosocomial outbreak of Kluyvera cryocrescens bacteremia. Infect Control Hosp Epidemiol 2002; 23: 62-4.
17. Brooks T, Feldman S. Central venous catheter infection in a child: case report and review of Kluyvera infection in children. South Med J 2003; 96: 214-7.
18. Thaller R, Berlutti F, Thaller MC. A Kluyvera cryocrescens strain from a gall-bladder infection. Eur J Epidemiol 1988; 4: 124-6.
19. Batìsta N, Díez Ó, Moreno A, Ode J. Colecistitis aguda por Kluyvera ascorbata. Enferm Infecc Microbiol Clin 2002; 20: 370-1.
20. Aevaliotis A, Belle AM. Kluyvera ascorbata Isolated from a baby with diarrhea. Clin Microbiol Newsl 1985; 7: 51.
21. Yogev R, Kozlowski S. Peritonitis due to Kluyvera ascorbata: case report and review. Rev Infect Dis 1990; 12: 399-402.
22. Sezer MT, Gültekin M, Günseren F, Erkiliç M, Ersoy F. A case of Kluyvera cryocrescens peritonitis in a CAPD patient. Perit Dial Int 1996; 16: 326-7.
23. Velusamy ,L, Mohanty MJ. Moraxella and Kluyvera peritonitis in a CAPD patient with human immunodeficiency virus. Perit Dial Int 2003; 23: 611-2.
24. Dollberg S, Gandacu A, Klar A. Acute pyelonephritis due to a Kluyvera species in a child. Eur J Clin Microbiol Infect Dis 1990; 9: 281-3.
25. Sanchis Bayarri V, Sánchez Sánchez R, Marcaida Benito G, Rambla RL. Infecciones por Kluyvera ascorbata. A propósito de dos casos. Rev Clin Esp 1992; 190: 187-8.
26. Medina López RA, Garcia Ramos JB, Congregado Ruíz B, Ortega Mariscal J, Sánchez Gómez E. Kluyuera ascorbata. Presentación de un caso en paciente con enfermedad de Crohn. Acta Urol Esp 2001; 25: 69-70.
27. Luttrell RE, Rannick GA, Soto-Hernandez JL, Verghese A. Kluyvera species soft tissue infection: case report and review. J Clin Microbiol 1988; 26: 2650-1.
28. West BC, Vijayan H, Shekar R. Kluyvera cryocrescens finger infection: case report and review of eighteen Kluyvera infections in human beings. Diagn Microbiol Infect Dis 1998; 32: 237-41.
29. Altwegg M, Zollinger-Iten J, von Graevenitz A. Differentiation of Kluyvera cryocrescens from Kluyvera ascorbata by irgasan susceptibility testing. Ann Inst Pasteur/Microbiol 1986; 137A: 159-68.
30. Stock I, Wiedemann B. Natural antibiotic, susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains. J Med Microbiol 2001; 50: 396-406.
31. Stock I, Wiedemann B. Natural β-lactam susceptibility and mechanisms of β-lactam resistance in Yersinía enterocolitica. Rev Med Microbiol 2000; 11: 197-210.
32. Deutsches Institut für Normung e.V. Susceptibility testing of pathogens to antimicrobial agents, part 4: Evaluation classes of the minimum inhibitory concentration. MIC break-points of antibacterial agents. DIN document 58940-4, Supplement 1. Deutsches Institut für Normung e.V., 2000, Berlin, Germany.
33. Comité de l'Antibiogramme de la Société Française de Microbiologie Communiqué. Statement. Pathol Biol 1998; 46: I-XVI.
34. Olsson-Liljequist B, Larson P, Walder M, Miömer H. Antimicrobial susceptibility testing in Sweden. Part 3: Methology for susceptibility testing. Scand J Infect Dis 1997; 105 (Suppl.): 13-23.
35. th edition. NCCLS document M7-A5. Villanova, PA: NCCLS, 2000.
36. th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto. Washington DC: American Society for Microbiology, 2000; 181.
37. th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto. Washington DC: American Society for Microbiology, 2000; 136.
38. European Committee on Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Linezolid breakpoints. Clin Microbiol Infect 2001; 7: 283-4.
39. Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
40. Decousser JW, Poirel I, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A β-lactamase from Kluyvera cryocrescens. Antimicrob Agents Chemother 2001; 45; 3595-8.
41. Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A. β-Lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M enzymes. Antimicrob Agents Chemother 2002; 46: 3045-9.
42. Poirel L, Kämpfer P, Nordmann P. Chromosome-encoded ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob Agents Chemother 2002; 46: 4038-40.
43. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000; 14: 137-42.
44. Nikaido H. Outer membrane. In: Neinhadt FC, editors. Escherichia coli and Salmonella Typhimurium, cellular and molecular biology. Washington, DC: American Society for Microbiology. 1996; pp. 29-47.
45. Plésiat P, Vaara M. Outer membrane permeability of the antibiotic-supersusceptible lipid A mutants of Escherichia coli to hydrophobic steroid probes. J Antimicrob Chemother 1999; 43: 608-10.
46. Farmer S, Li ZS, Hancock REW. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J Antimicrob Chemother 1992; 29: 27-33.
47. Hancock REW. Bacterial outer membrane: evolving concepts. Specific structures provide gram-negative bacteria with several unique advantages. ASM News 1991; 57: 175-82.